Heberden, W. : Some account of a disorder of the breast. Med. Trans. R. Coll. Physicians (Lond.), 2: 59, 1772.
2.
Kannel, W.B. , Feinleib, M.: Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am. J. Cardiol. , 29: 154, 1972.
3.
Block, W.J., Jr., Crumpacker, E.L. , Dry, T.J., et al.: Prognosis of angina pectoris. Observations in 6,882 cases. J.A.M.A., 150: 259, 1952.
4.
Reeves, T.J. , Oberman, A., Jones , W.B., et al.: Natural history of angina pectoris . Am. J. Cardiol., 33: 423, 1974.
5.
Hinkle, L.E. ;, Jr., Carver, S.T., Stevens , M.: The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middleaged men. Am. J. Cardiol., 24: 629, 1969.
6.
Coronary Drug Project Research Group: Prognostic importance of premature beats following myocardial infarction . J.A.M.A., 223: 1116, 1973.
7.
Vismara, L.A. , Hughes, J.L., Kraus , J., et al.: Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to post-hospital sudden death. Am. J. Cardiol., 33: 175, 1974.
8.
Kotler, M.N. , Tabatznik, B., Mower, M.M., et al.: Prognostic significance of ventricular ectopic beats with respect to sudden death in the late post-infarction period . Circulation , 47: 958, 1973.
9.
Lie, K.I., Wellens, H.J., Van Capelle, F.J., et al.: Lidocaine in the prevention of primary ventricular fibrillation: A double-blind randomized study of 212 consecutive patients. N. Engl. J. Med., 291: 1324, 1974.
10.
Wilhelmsson, C., Vedin, J.A., Tibblin , A., et al.: Reduction of sudden death after myocardial infarction by treatment with alprenolol. Lancet,2: 1157, 1974.
11.
A Multicentre International Study: Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. Br. Med. J., 3: 735, 1975.
12.
Ahlmark, G. , Saetre, H.: Long-term treatment with beta-blockers after myocardial infarction. Eur. J. Clin. Pharmacol., 10: 77, 1976.
Kosowsky, B.D. , Taylor, J., Lown , B., et al.: Long-term use of procaine amide following acute myocardial infarction. Circulation, 47: 1204, 1973 .
15.
Lown, B., Wolf, M.: Approaches to sudden death from coronary heart disease. Circulation , 44: 130, 1971.
16.
Rigo, P., Johnson, A., Detwiler, J., et al.: Comparative effectiveness of quinidine and propranolol for treating ventricular arrhythmias in patients with prior myocardial infarction . Circulation, 52 (Suppl. II): I I-230, 1975.
17.
Lewis, B.S. , Bakst, A., Mitka , A.S., et al.: Hemodynamic effects of a new beta-blocking agent "Sectral" (M&B 17803A). Br. Heart J., 35: 743, 1973.
18.
Gradman, A.H. , Winkle, R.A., Fitzgerald , J.W., et al.: Suppression of premature ventricular contractions by acebutolol. Circulation , 55(5): 785-791, 1977.
19.
Fitzgerald, J. , Clappier, R.R., Harrison , D.C.: Small computer processing of ambulatory arrhythmias, Computers In Cardiology. Bethesda, IEEE Conference, 1974, p. 31.
20.
Lopes, M.G. , Fitzgerald, J., Harrison , D.C., et al.: Diagnosis and quantification of arrhythmias in ambulatory patients using an improved R-R interval plotting system. Am. J. Cardiol., 35: 816, 1975.
21.
Winkle, R.A. , Meffin, P.J., Fitzgerald , J.W., et al.: Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide . Circulation , 54: 884, 1976.
22.
Goodman, L.S. , Gilman, A.: The Pharmacological Basis of Therapeutics . Second edition. New York , McMillan, 1955, p. 1831.
23.
Barner, H.B. , Kaiser, G.C., Willman , V.L.: Effect of nitroglycerin and papaverine on coronary flow in man. Am. Heart J., 88: 13, 1974.
24.
Parker, P.E. , Bashour, F.A., Downey , H.F., et al.: Coronary reperfusion: Effects of vasodilators (papaverine and adenosine). Am. Heart J., 93: 66, 1977.
25.
Lindner, E. , Katz, L.N.: Papaverine hydrochloride and ventricular fibrillation. Am. J. Physiol., 133: 155, 1941 .
26.
Wegria, R., Nickerson, N.D.: The effect of papaverine, epinephrine and quinidine on the fibrillation threshold of the mammalian ventricles. J. Pharmacol. Exp. Ther., 74: 50, 1942.
27.
Williams, E.M.V. , Szekeres, L.: A comparison of tests for antifibrillatory action. Br. J. Pharmacol., 17: 424, 1961.
28.
Leslie, A., Mulinos, M.G., Scott, J.W., Jr.: Coronary occlusion. II. Efficacy of papaverine hydrochloride in treatment of experimental cardiac infarction. Proc. Soc. Exp. Biol. Med., 44: 625, 1940.
